Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome

J Neurol Sci. 2015 Dec 15;359(1-2):211-2. doi: 10.1016/j.jns.2015.10.047. Epub 2015 Oct 28.

Authors

M Théaudin¹, E Elefant², M V Senat³

Affiliations

¹ Service de Neurologie adultes, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France. Electronic address: marie.theaudin@aphp.fr.
² Centre de référence sur les agents tératogènes, Hôpital Trousseau, APHP, 75571 Paris cedex 12, France.
³ Département de Gynécologie-Obstétrique, APHP, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Université Paris Sud, Paris, France.

PMID: 26671115
DOI: 10.1016/j.jns.2015.10.047

No abstract available

Keywords: Multiple sclerosis; Natalizumab; Pregnancy.

Publication types

Case Reports
Letter

MeSH terms

Adult
Female
Humans
Iris Diseases / drug therapy*
Magnetic Resonance Imaging
Natalizumab / therapeutic use*
Pregnancy

Substances

Natalizumab